Related Experiment Video
Updated: May 6, 2026
08:03
Multi-analyte Biochip MAB Based on All-solid-state Ion-selective Electrodes ASSISE for Physiological Research
Published on: April 18, 2013
17.7K
Multisystem Toxicity in Cancer: Lessons from NASA's Countermeasures Program.
Jessica M Scott1, Lianne B Dolan2, Larry Norton1
1Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical College, New York, NY, USA.
Cell
|November 16, 2019
Summary
NASA
Area of Science:
- Spaceflight physiology
- Oncology
- Translational medicine
Background:
- Spaceflight induces multisystem physiological toxicities.
- Cancer treatments also cause significant toxicities.
- These toxicities share commonalities between astronauts and cancer patients.
Purpose of the Study:
- To propose a novel countermeasures program (CMP) modeled after NASA's spaceflight research.
- To investigate the application of spaceflight-derived strategies for mitigating cancer-related toxicities.
- To elucidate and abrogate physiological toxicities in cancer patients.
Main Methods:
- Leveraging NASA's extensive experience in characterizing and mitigating spaceflight physiological effects.
- Adapting established countermeasures for the unique challenges of cancer patient care.
- Developing a framework for a NASA-modeled CMP in oncology.
Main Results:
- The proposed CMP offers a unique approach to managing cancer treatment side effects.
- Identifies potential overlaps in physiological responses to spaceflight and cancer therapy.
- Provides a foundation for future research into novel therapeutic strategies.
Conclusions:
- A NASA-modeled CMP holds promise for improving the quality of life for cancer patients.
- Cross-disciplinary approaches can yield innovative solutions in medicine.
- Further research is warranted to validate and implement this approach.
Related Concept Videos
02:59Biological Effects of Radiation
15.5K
All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they...
15.5K
02:56Treatment Resistant Cancers
2.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.7K
01:26Toxic Reactions: Overview
4.3K
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
4.3K
01:25Mutagenicity and Carcinogenicity
2.0K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
2.0K
01:00Drug Toxicity: Overview
313
Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
313
01:24Drug Toxicity: Dose-Dependent Reactions
245
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
245